6505--Amiodarone HCL Tablets

The Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal for a one-year contract with up to four one-year options to supply Amiodarone Hydrochloride (HCL) Tablets. This procurement supports multiple federal healthcare entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The awarded contract will ensure a continuous supply of the product, distributed through the VA’s and DoD’s Pharmaceutical Prime Vendor Programs. The solicitation requires that the drug be provided under the exact product name with a unique National Drug Code (NDC) specific to the offeror, and that labeling must adhere to strict requirements, including security of labels and specific safety packaging standards for unit-of-use bottles. The contract will cover three specific items: 100 mg Amiodarone HCL tablets in 30-count bottles, 200 mg tablets in both 60-count bottles and 500-count bulk packaging, with estimated annual usage totaling over 182,000 bottles across all sizes. The solicitation will be issued electronically around March 11, 2026, with proposals due by March 19, 2026. Interested offerors must monitor SAM.gov for updates and submit their proposals electronically, as no paper copies will be provided. The procurement falls under NAICS code 325412 and is managed by Contract Specialist Deb Fassl, who serves as the primary contact for questions and communications regarding this opportunity.